Methotrexate – rediscovered drug for Crohn’s disease

Czech version

Authors: M. Lukáš
Authors‘ workplace: Klinické a výzkumné centrum pro střevní záněty ISCARE I. V. F., a. s., Praha
Published in: Gastroent Hepatol 2018; 72(4): 367-368
Category:
doi: https://doi.org/10.14735/amgh2018367

Sources

1. Lukáš M. Metotrexát v terapii idiopatických střevních zánětů. Česká a slovenská gastroenterologie a hepatologie 2000; 54 (4): 156–161.

2. Feagan BG, Rochon J, Fedorak RN et al. Methotrexate for the treatment of Crohn‘s disease. The North American Crohn‘s Study Group Investigators. N Engl J Med 1995; 332: 292–297. doi: 10.1056/NEJM199502023320503.

3. Gomolón F, Dignas A, Vito A et al: 3^rd European evidence based consensuson the diagnosis and menagement of Crohn’s disease 2016. Part 1: Diagnosis and medical management. J Crohn’s Colitis 2017; 11 (1): 3–25. doi: 10.1093/ecco-jcc/jjw168.

4. Mc Donald JW, Wang Y, Tsoulis DJ et al. Methotrexate for induction of remission in refractory Crohn‘s disease. Cochrane Database Syst Rev 2014; 8: CD003459. doi: 10.1002/14651858.CD003459.pub4.